Table 2 Correlation of the tumor bed ratio with patient survival.

From: Intratumoral heterogeneity affects tumor regression and Ki67 proliferation index in perioperatively treated gastric carcinoma

 

Tumor bed ratio in quartiles

 

Quartile 1 (0–2%)

Quartile 2 (>2–12%)

Quartile 3 (>12–33%)

Quartile 4 (>33–100%)

 

n

(%)

n

(%)

n

(%)

n

(%)

Overall Survival [months]

96

      

0.093

Total/events/censored

22/10/12

24/11/13

25/15/10

25/16/9

Median Survival [years]

30.9 ± 6.4

32.2 ± 10.7

13.2 ± 5.5

19.8 ± 6.4

95% C.I.

[18.2–43.5]

[11.3–53.2]

[2.3–24.0]

[7.2–32.4]

Tumor Specific Survival [months]

96

      

0.116

Total/events/censored

22/10/12

24/7/17

25/11/14

25/13/12

Median Survival [years]

30.9 ± 6.4

n.c.

26.6 ± 12.8

22.1 ± 9.3

95% C.I.

[18.2–43.5]

n.c.

[1.5–51.7]

[3.9–40.4]